Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
24.76
-0.55 (-2.17%)
At close: Nov 3, 2025, 4:00 PM EST
25.24
+0.48 (1.94%)
After-hours: Nov 3, 2025, 5:18 PM EST
Arcutis Biotherapeutics Market Cap
Arcutis Biotherapeutics has a market cap or net worth of $3.03 billion as of November 3, 2025. Its market cap has increased by 166.94% in one year.
Market Cap
3.03B
Enterprise Value
2.94B
1-Year Change
166.94%
Ranking
Category
Stock Price
$24.76
Market Cap Chart
Since January 31, 2020, Arcutis Biotherapeutics's market cap has increased from $782.04M to $3.03B, an increase of 287.82%. That is a compound annual growth rate of 26.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 3.10B | 90.15% |
| Dec 31, 2024 | 1.63B | 434.82% |
| Dec 29, 2023 | 304.85M | -66.18% |
| Dec 30, 2022 | 901.45M | -13.58% |
| Dec 31, 2021 | 1.04B | -14.88% |
| Dec 31, 2020 | 1.23B | 56.71% |
| Jan 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.59B |
| Johnson & Johnson | 455.04B |
| AbbVie | 385.18B |
| UnitedHealth Group | 309.40B |
| AstraZeneca | 253.98B |
| Novartis AG | 237.13B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 214.96B |